Merit Medical Systems Inc (MMSI)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.41 (+1.38%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Merit Medical Systems Inc (MMSI)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.

Key Insights

Critical company metrics and information

  • Share Price

    $102.64

  • Market Cap

    $5.98 Billion

  • Total Outstanding Shares

    58.28 Million Shares

  • Total Employees

    6,950

  • Dividend

    No dividend

  • IPO Date

    February 26, 1992

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Homepage

    https://www.merit.com

Historical Stock Splits

If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
Execution DateSplit Amount
May 6, 20115-for-4
December 3, 20034-for-3
August 15, 20034-for-3

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$214.31 Million
Net Cash Flow From Investing Activities$-162.55 Million
Net Cash Flow From Financing Activities$410.37 Million
Net Cash Flow From Operating Activities$214.31 Million
Net Cash Flow, Continuing$462.13 Million
Net Cash Flow From Investing Activities, Continuing$-162.55 Million
Net Cash Flow$462.13 Million
Net Cash Flow From Financing Activities, Continuing$410.37 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Income Tax Expense/Benefit$28.28 Million
Cost Of Revenue$704.99 Million
Benefits Costs and Expenses$1.18 Billion
Net Income/Loss$120.04 Million
Provision For Loan, Lease, And Other Losses$1.27 Million
Operating Expenses$468.14 Million
Operating Income/Loss$152.74 Million
Costs And Expenses$1.18 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Gross Profit$620.88 Million
Revenues$1.33 Billion
Nonoperating Income/Loss$-4.43 Million
Diluted Earnings Per Share$2.05
Other Operating Expenses$83.73 Million
Basic Average Shares$116.35 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income/Loss From Continuing Operations After Tax$120.04 Million
Net Income/Loss Attributable To Parent$120.04 Million
Selling, General, and Administrative Expenses$384.41 Million
Income/Loss From Continuing Operations Before Tax$148.31 Million
Basic Earnings Per Share$2.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Available To Common Stockholders, Basic$120.04 Million
Diluted Average Shares$118.20 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Equity Attributable To Noncontrolling Interest$0.00
Noncurrent Assets$1.30 Billion
Other Non-current Assets$910.11 Million
Inventory$310.53 Million
Current Liabilities$201.08 Million
Equity$1.32 Billion
Noncurrent Liabilities$853.60 Million
Other Current Assets$767.79 Million
Current Assets$1.08 Billion
Long-term Debt$750.50 Million
Assets$2.38 Billion
Other Non-current Liabilities$103.09 Million
Fixed Assets$389.65 Million
Equity Attributable To Parent$1.32 Billion
Liabilities And Equity$2.38 Billion
Liabilities$1.05 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Merit Medical Systems Inc (MMSI)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.